Virpax Pharmaceuticals (VRPX) Announces 1:25 Reverse Share Split Mar 19, 2025 08:00AM
Virpax Pharmaceuticals (VRPX) Receives Positive Probudur Results for Dose Range Study Moves Towards Next Steps in IND Mar 18, 2025 04:01PM
Virpax Pharmaceuticals (VRPX) Reports Positive Results in Human Study for its Molecular Envelope Technology Feb 27, 2025 04:01PM
Virpax Pharmaceuticals (VRPX) Confirms Positive Results with US Army with Probudur for Combat Care Study Feb 13, 2025 04:01PM
Virpax Pharmaceuticals (VRPX) Prices $6M Offering at $0.20/sh Jan 28, 2025 09:15AM


Jan 15, 2025 04:35PM Virpax Pharmaceuticals (VRPX) Files for 16.85M Share and Warrant Offering
Dec 30, 2024 04:48PM Virpax Pharmaceuticals (VRPX) Files for Share and Warrant Offering
Nov 22, 2024 08:31AM Virpax Pharmaceuticals (VRPX) Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur
Nov 21, 2024 04:07PM Virpax Pharmaceuticals (VRPX) Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alt
Nov 13, 2024 09:16AM Virpax Pharmaceuticals (VRPX) Prices $5M Notes Offering at $0.50/sh
Oct 28, 2024 04:13PM Virpax Pharmaceuticals (VRPX) Files for 8.65M Share and Warrant Offering
Sep 17, 2024 04:17PM Virpax Pharmaceuticals (VRPX) Announces Resignation of Vanila M. Singh from Board
Aug 13, 2024 08:42AM Virpax Pharmaceuticals (VRPX) Misses Q2 EPS by 175c
Jul 24, 2024 07:30AM Virpax Pharmaceuticals (VRPX) Regains Nasdaq Compliance
Jul 10, 2024 07:30AM Virpax Pharmaceuticals (VRPX) Positive Results of Swine Model Pilot Study for Probudur